Linked Life Data

9082746

Source:http://linkedlifedata.com/resource/pubmed/id/9082746

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-4-2
pubmed:abstractText
Implantable cardioverters/defibrillators have greatly improved survival in patients with malignant ventricular arrhythmias. As modern devices and technical skill and experience reduce surgical complications attention is focussed on the potentially lethal infections of these devices. Staphylococcus spp. can be isolated as the predominant causative organisms. Devices that require thoracotomy (as opposed to transvene systems) and generator replacement (as opposed to primary implantation) carry a higher risk of infections. Although there are sporadic reports on successful conservative management of ICD infection, explantation of the generator, leads and patches followed by reimplantation of a new device after no less than 2 weeks is still the recommended procedure. Concomitant intravenous antibiotic therapy should be continued for 4 to 6 weeks.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0303-8173
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
164-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
[Infectious complications of cardioverter/defibrillators--case report and review of the literature].
pubmed:affiliation
Abteilung für Infektionen/Chemotherapie, Universitätsklinik für Innere Medizin, Wien.
pubmed:publicationType
Journal Article, English Abstract, Review, Case Reports